sitagliptin + metformin hydrochloride grindeks 50 mg + 1000 mg tabletki powlekane
as grindeks - sitagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 1000 mg
sitagliptin + metformin hydrochloride sandoz 50 mg + 1000 mg tabletki powlekane
sandoz gmbh - sitagliptini hydrochloridum monohydricum + metformini hydrochloridum - tabletki powlekane - 50 mg + 1000 mg
sitagliptin + metformin hydrochloride sandoz 50 mg + 850 mg tabletki powlekane
sandoz gmbh - sitagliptini hydrochloridum monohydricum + metformini hydrochloridum - tabletki powlekane - 50 mg + 850 mg
depepsit met 100 mg + 1000 mg tabletki o zmodyfikowanym uwalnianiu
adamed pharma s.a. - sitagliptin hydrochloride monohydrate + metformini hydrochloridum - tabletki o zmodyfikowanym uwalnianiu - 100 mg + 1000 mg
depepsit met 50 mg + 1000 mg tabletki o zmodyfikowanym uwalnianiu
adamed pharma s.a. - sitagliptin hydrochloride monohydrate + metformini hydrochloridum - tabletki o zmodyfikowanym uwalnianiu - 50 mg + 1000 mg
depepsit met 50 mg + 500 mg tabletki o zmodyfikowanym uwalnianiu
adamed pharma s.a. - sitagliptin hydrochloride monohydrate + metformini hydrochloridum - tabletki o zmodyfikowanym uwalnianiu - 50 mg + 500 mg
sitagliptin + metformin hydrochloride +pharma 50 mg + 1000 mg tabletki powlekane
+pharma arzneimittel gmbh - sitagliptini hydrochloridum monohydricum + metformini hydrochloridum - tabletki powlekane - 50 mg + 1000 mg
sitagliptin + metformin hydrochloride +pharma 50 mg + 850 mg tabletki powlekane
+pharma arzneimittel gmbh - sitagliptini hydrochloridum monohydricum + metformini hydrochloridum - tabletki powlekane - 50 mg + 850 mg
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - вилдаглиптин, metformina chlorowodorek - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 dla dostępnych danych o różnych kombinacjach).
jazeta 100 mg tabletki powlekane
zentiva, k.s. - sitagliptin hydrochloride monohydrate - tabletki powlekane - 100 mg